Skip to content
TrustList
venBio cover

About venBio

Artiva Biotherapeutics Establishes U.S. Research and Manufacturing Facility for NK Cell Therapy Pipeline Development and Clinical Supply

Artiva Biotherapeutics Establishes U S Research and Manufacturing Facility for NK Cell Therapy Pipeline Development and Clinical Supply

  • 2021 24 JUN Elevation Oncology Announces Pricing of Initial Public Offering posted by admin in Latest News Elevation Oncology Announces Pricing of Initial Public Offering
  • Read More
Elevation Oncology Announces Pricing of Initial Public Offering

Elevation Oncology Announces Pricing of Initial Public Offering

  • 2021 15 JUN RayzeBio Secures $108 Million Series C Financing to Drive Forward Its Pipeline of Targeted Radiopharmaceuticals for Cancer posted by admin in Latest News RayzeBio Secures $108 Million Series C Financing to Drive Forward Its Pipeline of Targeted Radiopharmaceuticals for Cancer
  • Read More
RayzeBio Secures $108 Million Series C Financing to Drive Forward Its Pipeline of Targeted Radiopharmaceuticals for Cancer

RayzeBio Secures $108 Million Series C Financing to Drive Forward Its Pipeline of Targeted Radiopharmaceuticals for Cancer

  • 2021 03 JUN venBio Raises $550 Million Venture Capital Fund Focused on Life Sciences posted by admin in Latest News venBio Raises $550 Million Venture Capital Fund Focused on Life Sciences
  • Read More
venBio Raises $550 Million Venture Capital Fund Focused on Life Sciences

venBio Raises $550 Million Venture Capital Fund Focused on Life Sciences

Categories & features

Request a demo or quote from venBio

Protected by reCAPTCHA — Google Privacy Policy and Terms apply.

By sending, you agree we may share your request and contact details with the provider once you confirm your email.

Reviews

Write the first review of venBio

Used it? Your experience helps other buyers decide.

Write a review

Questions & answers

No questions yet. Be the first to ask about venBio.

venBio alternatives

Similar listings buyers compare against this one.